They cracked the HBM monopoly with a bulk order, but the CFO just admitted margins are peaking because the factories are running at 100% capacity.
Thesis: This is a bottleneck arbitrage. ASMPT has transitioned from a legacy SMT cyclical to a critical HBM infrastructure play. The 'bulk order' from a leading HBM player validates their TCB tech against the incumbent. While SMT drags, the SEMI segment (53% of rev) is expanding margins to 48.6%. You are buying the HBM qualification and the capacity doubling; the legacy business is free optionality.
Verdict: LONG — Conviction: HIGH
Catalyst: Revenue recognition of the HBM bulk order in Q4/Q1 and announcement of a foundry chip-to-wafer win.
Key Risk: Hybrid bonding acceleration. If 16-high HBM skips TCB directly to hybrid bonding, the addressable market collapses.
The Tell: CFO Katie Xu: 'Actually, capacity was — the utilization was running almost at 100%.' This slip reveals that the massive 406bps margin expansion wasn't just mix/pricing, it was a physical limit. They are maxed out.
Friction Level: MODERATE_FRICTION — Bears see TCB as a transitional tech being displaced by hybrid bonding. Bulls see TCB as the persistent bottleneck for HBM12/16/20, with ASMPT capturing the second-source share.
Report not found
The report data is no longer available. Please return to the archive.